RYTM vs. HIMS
RYTM (Rhythm Pharmaceuticals, Inc.) and HIMS (Hims & Hers Health, Inc.) are both stocks. RYTM operates in Biotechnology (Healthcare), while HIMS operates in Household & Personal Products (Consumer Defensive). Over the past 5 years, RYTM returned 35.24%/yr vs 15.10%/yr for HIMS. At a 0.24 correlation, their price movements are largely independent.
Performance
RYTM vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RYTM achieves a -19.73% return, which is significantly lower than HIMS's -16.32% return.
RYTM
- 1D
- -0.55%
- 1M
- -8.76%
- YTD
- -19.73%
- 6M
- -18.31%
- 1Y
- 26.16%
- 3Y*
- 70.19%
- 5Y*
- 35.24%
- 10Y*
- —
HIMS
- 1D
- 3.74%
- 1M
- -3.89%
- YTD
- -16.32%
- 6M
- -30.55%
- 1Y
- -51.77%
- 3Y*
- 44.53%
- 5Y*
- 15.10%
- 10Y*
- —
RYTM vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
RYTM Rhythm Pharmaceuticals, Inc. | -19.73% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | 0.09% |
HIMS Hims & Hers Health, Inc. | -16.32% | 34.28% | 171.69% | 38.85% | -2.14% | -55.14% | 47.47% | 1.23% |
Correlation
The correlation between RYTM and HIMS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.24 |
The correlation between RYTM and HIMS shifts across timeframes, from 0.16 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
RYTM:
$5.84B
HIMS:
$6.20B
RYTM:
-$3.10
HIMS:
-$0.05
RYTM:
26.00
HIMS:
2.81
RYTM:
712.63
HIMS:
13.91
RYTM:
$217.17M
HIMS:
$2.37B
RYTM:
$194.16M
HIMS:
$1.70B
RYTM:
-$182.86M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RYTM vs. HIMS — Risk / Return Rank
RYTM
HIMS
RYTM vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYTM | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.00 | ||
| Sortino ratioReturn per unit of downside risk | +1.69 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.95 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.74 | -0.67 | +1.40 |
| Martin ratioReturn relative to average drawdown | 1.74 | -1.09 | +2.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RYTM | HIMS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.46 | -0.54 | +1.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.46 | 0.18 | +0.28 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | 0.21 | -0.03 |
Drawdowns
RYTM vs. HIMS - Drawdown Comparison
The maximum RYTM drawdown since its inception was -92.10%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for RYTM and HIMS.
Loading charts...
Drawdown Indicators
| RYTM | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.10% | -87.29% | -4.81% |
Max Drawdown (1Y)Largest decline over 1 year | -35.54% | -78.06% | +42.52% |
Max Drawdown (3Y)Largest decline over 3 years | -35.54% | -78.88% | +43.34% |
Max Drawdown (5Y)Largest decline over 5 years | -85.49% | -78.88% | -6.61% |
Current DrawdownCurrent decline from peak | -26.95% | -60.47% | +33.52% |
Average DrawdownAverage peak-to-trough decline | -32.18% | -43.22% | +11.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.08% | 47.51% | -32.43% |
Volatility
RYTM vs. HIMS - Volatility Comparison
The current volatility for Rhythm Pharmaceuticals, Inc. (RYTM) is 14.47%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 26.28%. This indicates that RYTM experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RYTM | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.47% | 26.28% | -11.81% |
Volatility (6M)Calculated over the trailing 6-month period | 36.66% | 66.46% | -29.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.36% | 96.13% | -38.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.40% | 83.39% | -6.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.96% | 77.19% | -6.23% |
Dividends
RYTM vs. HIMS - Dividend Comparison
Neither RYTM nor HIMS has paid dividends to shareholders.
Financials
RYTM vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Rhythm Pharmaceuticals, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RYTM vs. HIMS - Profitability Comparison
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
HIMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
HIMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
HIMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.
Frequently Asked Questions
RYTM and HIMS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HIMS has higher volatility (26.28%) compared to RYTM (14.47%). In terms of maximum drawdown, RYTM dropped -92.10% vs HIMS's -87.29%.
RYTM currently has the higher Sharpe Ratio (0.46 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RYTM and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer